Pediatric Trials Network Long-term Antipsychotic Pediatric Safety Trial (LAPS) NICHD-2016-LAP01 Phase 4 Trial
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone (Primary)
- Indications Autistic disorder; Bipolar disorders; Schizophrenia
- Focus Adverse reactions
- Acronyms LAPS
- 08 Jan 2019 Status changed from not yet recruiting to recruiting.
- 12 Dec 2018 Planned initiation date changed from 30 Oct 2018 to 30 Jan 2019.
- 18 Oct 2018 Planned initiation date changed from 30 Jul 2018 to 30 Oct 2018.